Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial

Title:	Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial
Authors:	Long, Georgina V.^{Aff1, Aff2, Aff3, Aff4, Aff5, IDs41591024030775_cor1}; Carlino, Matteo S.^{Aff1, Aff2, Aff6, Aff7}; Au-Yeung, George^{Aff8, Aff9}; Spillane, Andrew J.^{Aff1, Aff2, Aff3, Aff4}; Shannon, Kerwin F.^{Aff1, Aff2, Aff4, Aff10, Aff11, Aff12}; Gyorki, David E.^{Aff8, Aff9}; Hsiao, Edward^Aff3; Kapoor, Rony^{Aff4, Aff13}; Thompson, Jake R.^{Aff1, Aff2}; Batula, Iris^{Aff1, Aff2}; Howle, Julie^Aff6; Ch’ng, Sydney^{Aff1, Aff2, Aff4, Aff10, Aff11}; Gonzalez, Maria^Aff1; Saw, Robyn P. M.^{Aff1, Aff2, Aff4, Aff10}; Pennington, Thomas E.^{Aff1, Aff2, Aff4, Aff10}; Lo, Serigne N.^{Aff1, Aff2}; Scolyer, Richard A.^{Aff1, Aff2, Aff5, Aff10, Aff11, Aff14}; Menzies, Alexander M.^{Aff1, Aff2, Aff3, Aff4}
Source:	Nature Medicine. 30(9):2540-2548
Database:	Springer Nature Journals